Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
((20S)-20-carbamoyl-3,6,9,12,15,18,22-heptaoxo-8,17-bis((quinoxaline-2-carboxamido)methyl)-1,4,7,10,13,16,19-heptaazacyclodocosan-2-yl)methanaminium
ID: ALA4520839
PubChem CID: 155542549
Max Phase: Preclinical
Molecular Formula: C37H41N15O10
Molecular Weight: 855.83
Molecule Type: Unknown
Associated Items: